April 16, 2026 · Form 4 insider transaction
Henderson Jane sold 2,000 shares of Apogee Therapeutics, Inc. at $90.00 per share, a transaction worth $180.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 2, 2025.